Effectiveness of Dupilumab in Pediatric Patient With Prurigo Nodularis-Like Atopic Dermatitis

Dermatitis. 2023 Mar-Apr;34(2):162-163. doi: 10.1089/derm.2022.29008.yyi. Epub 2023 Jan 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Child
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Neurodermatitis*
  • Prurigo* / drug therapy
  • Pruritus
  • Treatment Outcome

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized